New Post Public Reply Private Reply Replies (0) Message Board ← Newer Older → News Desk 2018 Aug 17, 2017 at 9:00 AM 72 Protalex, Inc. (PRTX: OTCQB) | Protalex Awarded Grant from FDA Office of Orphan Products Development to Foster Clinical Development of PRTX-100 for the Treatment of Immune Thrombocytopenia Newer Older
